HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapeutic administration of Y-40138, a multiple cytokine modulator, inhibits concanavalin A-induced hepatitis in mice.

Abstract
Concanavalin A-induced hepatitis is often used as a model of liver injury. In this model, plasma tumor necrosis factor-alpha (TNF-alpha) level increased in concanavalin A-injected mice. Prophylactic treatment with Y-40138, N-[1-(4-[4-(pyrimidin-2-yl)piperazin-1-yl]methyl phenyl)cyclopropyl] acetamide.HCl, significantly suppressed the increase in plasma TNF-alpha level. In this study, we compared the effect of Y-40138 with those of pentoxifylline and anti-TNF-alpha antibody on concanavalin A-induced hepatitis. Prophylactic treatment with pentoxifylline, anti-TNF-alpha antibody and Y-40138 reduced plasma alanine aminotransferase level. Therapeutic treatment with Y-40138 significantly reduced plasma alanine aminotransferase level, but pentoxifylline and anti-TNF-alpha antibody did not. Therapeutic treatment with Y-40138 significantly reduced plasma interferon-gamma (IFN-gamma) and monokine induced by interferon-gamma levels. From these results, Y-40138 may be expected as a new class of therapeutic drug for treatment of TNF-alpha, IFN-gamma and/or chemokine-related liver diseases such as alcoholic liver disease.
AuthorsTetsuko Fukuda, Akira Mogami, Masao Hisadome, Hirotsugu Komatsu
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 523 Issue 1-3 Pg. 137-42 (Oct 31 2005) ISSN: 0014-2999 [Print] Netherlands
PMID16236280 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Acetamides
  • Antibodies
  • Chemokines, CXC
  • Cytokines
  • Piperazines
  • Tumor Necrosis Factor-alpha
  • Y 39041
  • Concanavalin A
  • Interferon-gamma
  • Alanine Transaminase
  • Pentoxifylline
Topics
  • Acetamides (administration & dosage, therapeutic use)
  • Alanine Transaminase (blood)
  • Animals
  • Antibodies (administration & dosage, therapeutic use)
  • Chemical and Drug Induced Liver Injury (blood, etiology, prevention & control)
  • Chemokines, CXC (blood)
  • Concanavalin A (adverse effects)
  • Cytokines (blood)
  • Disease Models, Animal
  • Female
  • Interferon-gamma (blood)
  • Mice
  • Mice, Inbred BALB C
  • Pentoxifylline (administration & dosage, therapeutic use)
  • Piperazines (administration & dosage, therapeutic use)
  • Premedication
  • Time Factors
  • Tumor Necrosis Factor-alpha (analysis, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: